Protalix BioTherapeutics PLX Balance Sheet (2009-2026)

NYSE PLX
$3.13 +0.28 (+9.62%)
As of: Nov 11, 2026 · 3:59 PM EST
Reported Financials

Protalix BioTherapeutics Quarterly Balance Sheet

Periods 71 quarters
Latest Sep 2026

Protalix BioTherapeutics reported total assets of $118.24M and total liabilities of $37.69M for the quarter ended Sep 2026, up 43.7% year over year. This balance sheet covers 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
38.99M16.89M12.49M10.72M17.11M33.04M48.18M20.41M23.63M27.21M23.40M27.41M19.76M19.46M17.90M13.65M14.68M41.00M27.42M22.04M
Short-term InvestmentsInvestments (Current)
16.03M16.08M10.09M5.07M20.57M20.93M21.28M21.63M15.07M15.29M15.50M15.72M15.59M10.08M13.24M26.50M
Cash & Current Investments
38.99M32.92M28.57M20.81M22.18M33.04M48.18M40.98M44.56M48.49M45.03M27.41M34.83M34.74M33.40M29.37M30.27M51.08M40.66M48.54M
Receivables - NetNet Receivables
3.44M5.91M2.02M8.65M4.59M1.30M4.05M8.94M5.27M3.76M10.13M2.20M2.91M4.68M9.44M14.43M8.84M2.94M16.50M13.91M
Receivables - OtherOther Receivables
Receivables
3.44M5.91M2.02M8.65M4.59M1.30M4.05M8.94M5.27M3.76M10.13M2.20M2.91M4.68M9.44M14.43M8.84M2.94M16.50M13.91M
Raw Materials
3.17M3.07M3.30M3.66M3.51M4.31M4.35M4.20M4.18M4.02M4.30M4.24M4.55M4.48M4.36M4.98M5.98M6.01M6.08M
Work In Process
3.26M3.37M3.30M2.62M2.68M1.53M3.32M9.12M9.06M9.17M10.87M12.25M11.25M8.00M8.14M5.36M9.38M9.08M8.25M
Finished Goods
11.53M10.16M9.91M8.28M10.62M14.46M11.97M8.27M5.81M9.15M5.54M0.71M5.45M7.02M8.63M10.92M10.37M15.38M17.96M
Inventory
17.95M16.59M16.51M14.56M16.80M20.30M19.64M21.58M19.05M22.35M20.72M17.20M21.24M19.51M21.13M21.26M25.73M30.47M32.29M34.30M
Prepaid Assets
0.91M0.77M0.44M0.50M0.39M
Current Assets
61.67M56.54M49.70M45.76M44.88M55.40M73.58M72.62M69.93M75.40M77.37M47.85M60.08M60.51M65.49M66.50M66.67M86.36M92.22M98.87M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
4.96M4.89M4.77M4.68M4.55M4.70M4.64M4.68M4.97M4.78M4.61M4.65M4.59M4.73M4.75M4.72M4.88M5.15M5.47M5.77M
Long-Term Investments
Long-Term Deferred Tax
3.13M3.09M3.09M3.23M3.30M2.86M2.86M2.97M2.74M2.68M2.52M2.45M2.37M2.30M
Other Non-Current Assets
1.29M1.12M2.60M1.74M1.31M0.76M1.71M1.13M1.06M0.81M1.49M1.05M1.10M1.59M1.51M1.45M1.13M1.15M2.05M1.40M
Non-Current Assets
12.00M11.85M10.94M10.95M10.91M11.16M14.84M14.95M14.50M14.42M14.17M13.71M13.34M13.38M13.00M15.76M15.67M15.98M18.12M19.37M
Assets
73.67M68.39M60.64M56.71M55.79M66.56M88.42M87.57M84.43M89.83M91.54M61.56M73.42M73.89M78.49M82.26M82.35M102.34M110.34M118.24M
Liabilities
Current Liabilities
Accounts Payables
6.99M7.87M6.99M5.64M5.86M5.11M3.30M3.11M4.32M3.15M4.06M3.14M4.53M4.12M6.69M5.38M5.26M4.29M6.51M4.78M
Notes Payables
Payables
6.99M7.87M6.99M5.64M5.86M5.11M3.30M3.11M4.32M3.15M4.06M3.14M4.53M4.12M6.69M5.38M5.26M4.29M6.51M4.78M
Accumulated Expenses
11.98M9.52M8.45M9.39M8.34M9.57M9.35M7.31M8.13M9.79M9.69M9.96M
Other Accumulated Expenses
16.43M14.41M12.66M12.87M12.27M13.47M18.55M18.74M0.64M18.77M19.34M19.58M1.08M0.30M0.76M0.56M0.80M0.97M1.56M23.77M
Short term Debt
20.19M20.25M20.42M20.42M
Current Taxes
2.88M2.88M2.88M3.04M3.48M3.48M3.74M2.39M2.95M3.20M4.22M
Current Deferred Revenue
8.55M11.80M10.22M14.79M13.18M11.79M11.04M12.70M2.00M
Total Current Liabilities
33.18M35.33M30.96M34.30M32.43M31.52M23.11M43.36M45.53M54.83M57.97M24.22M25.62M24.32M24.09M21.95M26.52M27.39M31.39M30.23M
Non-Current Liabilities
Non-Current Debt
Convertible Debt
27.89M27.96M28.03M28.11M28.19M28.27M20.13M20.19M20.42M20.42M20.42M
Non-Current Deferred Revenue
11.79M5.90M5.90M
Pension
2.47M2.50M1.75M1.78M1.64M1.62M1.60M1.46M0.71M0.71M0.71M0.73M0.56M0.55M0.62M0.63M0.66M0.67M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
Operating Leases
4.38M4.19M3.89M4.03M4.17M4.15M4.58M4.50M4.62M4.50M4.28M4.18M4.03M3.81M3.88M6.78M6.94M7.05M7.54M1.69M
Other Non-Current Liabilities
Total Non-Current Liabilities
46.53M40.55M39.57M33.92M34.00M34.04M26.31M5.96M5.34M5.21M4.99M4.91M4.59M4.36M4.49M7.41M7.60M7.72M7.54M7.46M
Total Liabilities
79.70M75.88M70.53M68.22M66.43M65.55M49.42M49.32M50.87M60.04M62.96M29.13M30.21M28.68M28.58M29.36M34.12M35.11M38.93M37.69M
Shareholder's Equity
Total Debt
20.19M20.25M20.42M20.42M
Common Equity
-6.04M-7.49M-9.89M-11.51M-10.64M1.01M39.00M38.25M33.57M29.79M28.58M32.44M43.21M45.21M49.90M52.91M48.23M67.23M71.40M80.55M
Liabilities and Shareholders Equity
73.67M68.39M60.64M56.71M55.79M66.56M88.42M87.57M84.43M89.83M91.54M61.56M73.42M73.89M78.49M82.26M82.35M102.34M110.34M118.24M
Retained Earnings
-374.93M-389.86M-381.55M-378.39M-385.00M

Protalix BioTherapeutics Balance Sheet API

Pull Protalix BioTherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PLX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY